Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-EN
Language French English
Date Updated 2017-11-23 2017-09-29
Drug Identification Number 02241999 02241999
Brand name CARBOCAINE 1% CARBOCAINE 1%
Common or Proper name CARBOCAINE CARBOCAINE
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients MEPIVACAINE HYDROCHLORIDE MEPIVACAINE HYDROCHLORIDE
Strength(s) 1% 1%
Dosage form(s) SOLUTION SOLUTION
Route of administration EPIDURAL INTRACAUDAL EPIDURAL INTRACAUDAL
Packaging size 10x30ml 10x30ml
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2017-09-28 2017-09-28
Actual start date
Estimated end date Unknown Unknown
Actual end date 2017-09-30
Shortage status Resolved Actual shortage
Company comments Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions. Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.
Health Canada comments